Lung Toolkit: a tailored education program to help AI/AN cigarette smokers learn about lung cancer and screening
Official title: Lung Health Promotion for AI/AN People Through Human Center Design (Lung PATHS) - Aim 3 Intervention
Run by Fred Hutchinson Cancer Center · NCT07615764 · Data updated 2026-11-12
A Lung Toolkit education program is tested to see if it improves knowledge about lung cancer and screening among American Indian and Alaska Native cigarette smokers aged 50–80.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Fred Hutchinson Cancer Center Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | December 1, 2026 |
| Main results expected | March 31, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07615764 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50–80 who self-identify as AI/AN, have at least a 10 pack-year history of commercial tobacco use, and can consent in English.
✕Probably not a fit
Individuals with no interest in lung cancer screening or those outside the 50–80 age range may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study provides AI/AN adults who smoke with a culturally tailored Lung Toolkit, consisting of a website and a physical pouch, plus a guided review session. Participants then use the toolkit materials for 30 days to increase awareness of lung health and screening options. The study measures acceptability and knowledge gain after the intervention and collects questionnaire data to understand reach and adherence. The toolkit links to resources on smoking cessation, screening, and community stories to support engagement. The intervention is delivered at Fred Hutch/UW Cancer Consortium in Seattle, with collaboration from Bristol-Myers Squibb.
Why it matters
Potential benefit: If successful, participants may gain better understanding of lung cancer risk and screening options, potentially encouraging informed health decisions.
How similar studies have gone: Previous education-based approaches in other populations have improved knowledge; the AI/AN tailoring is novel for this specific group.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between ages 50-80 * Self-identify as AI/AN * Self-reported 10 pack-year smoking history (commercial tobacco i.e. cigarettes) * Ability to understand and indicate informed consent Exclusion Criteria: * Not between ages 50-80 * Having less than a 10 pack-year history of smoking commercial tobacco * Inability to communicate in written and verbal English * Having any cognitive impairment that compromises the ability to provide informed consent
Where it's running
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Matthew Triplette, MD, MPH — Fred Hutch/University of Washington Cancer Consortium
- Study coordinator: Nicolas Anderson
- Email: nanders3@fredhutch.org
- Phone: 206.667.5434
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Couples Coping Together Against Cancer: A Feasibility and Acceptability Look
This observational study tests whether a brokered program for patients with cancer and their partners is feasible and acceptable, and whether it may reduce distress over time.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
Restorative Justice–Based Lung Cancer Screening Support for Black Individuals to See if Screening Increases Uptake
This trial tests a restorative justice–based decision-making support to see if it increases lung cancer screening among Black adults who smoke or recently stopped.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
Support for Veterans with lung cancer.
This study will test whether weekly phone support from a trained lay health worker can improve quality of life for Veterans who are newly diagnosed with lung cancer or who finished treatment within the past year.
-
Tailored Patient Navigation to Boost Lung Cancer Screening in Tribal Communities
This trial tests whether customized patient navigation can help American Indian and Alaska Native people in western Washington start and complete lung cancer screening.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.